Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
PaperCitations, authors & open-access status
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 582 citations, 2013 year and hybrid oa status.
582
Citations
2013
Year
hybrid
OA Status